ABL1 and leukemia: Furthermore, to assess if leukemia-induced decrease in miR-142 levels and activity of T cells could be rescued by blocking IL-6, we transplanted BM cells from Mir142−/−BCR-ABL mice (CD45.2) into congenic normal wt recipients (CD45.1, 106/mouse).